Literature DB >> 15887289

Prenatal mucolipidosis type II (I-cell disease) can present as Pacman dysplasia.

Robert A Saul1, Virginia Proud, Harold A Taylor, Jules G Leroy, Jurgen Spranger.   

Abstract

Pacman dysplasia has been previously reported to be a lethal skeletal dysplasia with epiphyseal stippling and osteoclastic overactivity. We report on a sibling of a fetus previously reported as Pacman dysplasia. This infant has a clinical course consistent with mucolipidosis type II (I-cell disease) along with confirmatory biochemical, cytologic, and radiographic evidence. This case expands the phenotypic spectrum of mucolipidosis type II. Having redefined the diagnosis in one of the original cases of Pacman dysplasia, we suggest that what is called Pacman dysplasia could very well be Mucolipidosis type II (ML-II) in other published reports.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15887289     DOI: 10.1002/ajmg.a.30716

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  8 in total

Review 1.  Lysosomal storage disorders in the newborn.

Authors:  Orna Staretz-Chacham; Tess C Lang; Mary E LaMarca; Donna Krasnewich; Ellen Sidransky
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

Review 2.  Molecular analysis of the GlcNac-1-phosphotransferase.

Authors:  T Braulke; S Pohl; S Storch
Journal:  J Inherit Metab Dis       Date:  2008-04-15       Impact factor: 4.982

3.  Early characteristic radiographic changes in mucolipidosis II.

Authors:  Lillian M Lai; Ralph S Lachman
Journal:  Pediatr Radiol       Date:  2016-08-15

4.  Phenotype and genotype in mucolipidoses II and III alpha/beta: a study of 61 probands.

Authors:  S S Cathey; J G Leroy; T Wood; K Eaves; R J Simensen; M Kudo; R E Stevenson; M J Friez
Journal:  J Med Genet       Date:  2009-07-16       Impact factor: 6.318

5.  Challenges in Diagnosing Rare Genetic Causes of Common In Utero Presentations: Report of Two Patients with Mucolipidosis Type II (I-Cell Disease).

Authors:  Gregory Costain; Michal Inbar-Feigenberg; Maha Saleh; Shimrit Yaniv-Salem; Greg Ryan; Eric Morgen; Elaine S Goh; Gen Nishimura; David Chitayat
Journal:  J Pediatr Genet       Date:  2018-03-09

6.  Pitfalls in the prenatal diagnosis of mucolipidosis II alpha/beta: A case report.

Authors:  Taciane Alegra; Tiago Koppe; Angelina Acosta; Manoel Sarno; Maira Burin; Rejane Gus Kessler; Fernanda Sperb-Ludwig; Gabriela Cury; Guilherme Baldo; Ursula Matte; Roberto Giugliani; Ida Vanessa D Schwartz
Journal:  Meta Gene       Date:  2014-06-01

7.  Upregulation of Sortilin, a Lysosomal Sorting Receptor, Corresponds with Reduced Bioavailability of Latent TGFβ in Mucolipidosis II Cells.

Authors:  Jarrod W Barnes; Megan Aarnio-Peterson; Joy Norris; Mark Haskins; Heather Flanagan-Steet; Richard Steet
Journal:  Biomolecules       Date:  2020-04-26

8.  A case of mucolipidosis II presenting with prenatal skeletal dysplasia and severe secondary hyperparathyroidism at birth.

Authors:  Ju Sun Heo; Ka Young Choi; Se Hyoung Sohn; Curie Kim; Yoon Joo Kim; Seung Han Shin; Jae Myung Lee; Juyoung Lee; Jin A Sohn; Byung Chan Lim; Jin A Lee; Chang Won Choi; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi
Journal:  Korean J Pediatr       Date:  2012-11-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.